97 related articles for article (PubMed ID: 27667587)
1. Expression pattern of CD55 and CD59 on red blood cells in sickle cell disease.
Al-Faris L; Al-Rukhayes M; Al-Humood S
Hematology; 2017 Mar; 22(2):105-113. PubMed ID: 27667587
[TBL] [Abstract][Full Text] [Related]
2. Altered Expression Pattern of CD55 and CD59 on Red Blood Cells in Anemia of Chronic Kidney Disease.
Al-Faris L; Al-Humood S; Behbehani F; Sallam H
Med Princ Pract; 2017; 26(6):516-522. PubMed ID: 28957817
[TBL] [Abstract][Full Text] [Related]
3. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.
Barros MM; Yamamoto M; Figueiredo MS; Cançado R; Kimura EY; Langhi DM; Chiattone CS; Bordin JO
Transfusion; 2009 Jan; 49(1):154-60. PubMed ID: 18954403
[TBL] [Abstract][Full Text] [Related]
4. Altered Expression Levels of CD59, but Not CD55, on Red Blood Cells in Stored Blood.
Al-Faris L; Al-Humood S
Med Princ Pract; 2019; 28(4):361-366. PubMed ID: 30844815
[TBL] [Abstract][Full Text] [Related]
5. Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection.
Terpos E; Sarantopoulos A; Kouramba A; Katsarou O; Stavropoulos J; Masouridi S; Karafoulidou A; Meletis J
Med Sci Monit; 2008 May; 14(5):CR276-280. PubMed ID: 18443552
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria.
Ruiz-Delgado GJ; Vázquez-Garza E; Méndez-Ramírez N; Gómez-Almaguer D
Hematology; 2009 Feb; 14(1):33-7. PubMed ID: 19154662
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients.
Alegretti AP; Mucenic T; Merzoni J; Faulhaber GA; Silla LM; Xavier RM
Cell Immunol; 2010; 265(2):127-32. PubMed ID: 20727519
[TBL] [Abstract][Full Text] [Related]
8. Compensation of CD55 Underexpression on Red Blood Cells of β-Thalassemia Major Patients.
Obaid JM; Abo El-Nazar SY; Ghanem AM; El-Hadidi AS; Mersal BH
Hemoglobin; 2015; 39(3):184-9. PubMed ID: 25897480
[TBL] [Abstract][Full Text] [Related]
9. Recombinant EPO therapy increases erythrocyte expression of complement regulatory proteins.
Ohi H; Tamano M; Sudo S; Okada N
Am J Kidney Dis; 2003 Jan; 41(1):179-85. PubMed ID: 12500235
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD55 on red blood cells of β-thalassemia patients.
Obaid JM; Abo El-Nazar SY; Ghanem AM; El-Hadidi AS; Mersal BH
Hemoglobin; 2014; 38(5):339-44. PubMed ID: 25026028
[TBL] [Abstract][Full Text] [Related]
11. Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia.
García-Valladares I; Atisha-Fregoso Y; Richaud-Patin Y; Jakez-Ocampo J; Soto-Vega E; Elías-López D; Carrillo-Maravilla E; Cabiedes J; Ruiz-Argüelles A; Llorente L
Lupus; 2006; 15(9):600-5. PubMed ID: 17080916
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of CD55 and CD59 expression on blood cells in paroxysmal nocturnal haemoglobinuria.
Dworacki G; Sikora J; Mizera-Nyczak E; Trybus M; Mozer-Lisewska I; Czyz A; Zeromski J
Folia Histochem Cytobiol; 2005; 43(2):117-20. PubMed ID: 16044949
[TBL] [Abstract][Full Text] [Related]
13. The effects of marathon running on expression of the complement regulatory proteins CD55 (DAF) and CD59 (MACIF) on red blood cells.
Simpson RJ; Florida-James GD; Whyte GP; Middleton N; Shave R; George K; Guy K
Eur J Appl Physiol; 2007 Jan; 99(2):201-4. PubMed ID: 17089158
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of different flow cytometry-based immunophenotypic methods for the analysis of CD59 and CD55 expression on major peripheral blood cell subsets.
Hernández-Campo PM; Martín-Ayuso M; Almeida J; López A; Orfao A
Cytometry; 2002 Jun; 50(3):191-201. PubMed ID: 12116342
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of CD55 and CD59 expression on reticulocytes and mature erythrocytes in paroxysmal nocturnal hemoglobinuria, aplastic anemia, and healthy control subjects.
Kim Y; Lim J; Kim M; Kim Y; Lee JW; Han K
Ann Clin Lab Sci; 2010; 40(3):226-32. PubMed ID: 20689133
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of complement regulatory proteins, CD55 and CD59, on peripheral blood leucocytes in patients with type 2 diabetes and macrovascular diseases.
Ma XW; Chang ZW; Qin MZ; Sun Y; Huang HL; He Y
Chin Med J (Engl); 2009 Sep; 122(18):2123-8. PubMed ID: 19781296
[TBL] [Abstract][Full Text] [Related]
17. Use of complement regulators, CD35, CD46, CD55, and CD59, on leukocytes as markers for diagnosis of viral and bacterial infections.
Nuutila J; Jalava-Karvinen P; Hohenthal U; Kotilainen P; Pelliniemi TT; Nikoskelainen J; Lilius EM
Hum Immunol; 2013 May; 74(5):522-30. PubMed ID: 23376460
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of erythrocytes in paroxysmal nocturnal hemoglobinuria reveals superiority of CD59 as a diagnostic marker compared to CD55.
Tembhare P; Ramani M; Syed K; Gupta AD
Indian J Pathol Microbiol; 2010; 53(4):699-703. PubMed ID: 21045396
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus.
Richaud-Patin Y; Pérez-Romano B; Carrillo-Maravilla E; Rodriguez AB; Simon AJ; Cabiedes J; Jakez-Ocampo J; Llorente L; Ruiz-Argüelles A
Immunol Lett; 2003 Aug; 88(2):95-9. PubMed ID: 12880676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
